APA

Böhm M. J., Marienfeld R., Jäger D., Mellert K., von Witzleben A., Brüderlein S., Wittau M., von Baer A., Schultheiss M., Mayer-Steinacker R., Rücker F. G., Möller P., Bullinger L. & Barth T. F. E. (2019). Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib. : Sarcoma.

Chicago

Böhm Michael J, Marienfeld Ralf, Jäger Daniela, Mellert Kevin, von Witzleben Adrian, Brüderlein Silke, Wittau Mathias, von Baer Alexandra, Schultheiss Markus, Mayer-Steinacker Regine, Rücker Frank G, Möller Peter, Bullinger Lars and Barth Thomas F E. 2019. Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib. : Sarcoma.

Harvard

Böhm M. J., Marienfeld R., Jäger D., Mellert K., von Witzleben A., Brüderlein S., Wittau M., von Baer A., Schultheiss M., Mayer-Steinacker R., Rücker F. G., Möller P., Bullinger L. and Barth T. F. E. (2019). Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib. : Sarcoma.

MLA

Böhm Michael J, Marienfeld Ralf, Jäger Daniela, Mellert Kevin, von Witzleben Adrian, Brüderlein Silke, Wittau Mathias, von Baer Alexandra, Schultheiss Markus, Mayer-Steinacker Regine, Rücker Frank G, Möller Peter, Bullinger Lars and Barth Thomas F E. Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib. : Sarcoma. 2019.